These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31564570)

  • 1. Tumour Budding and Tumour Stroma Ratio are Reliable Predictors for Death and Recurrence in Elderly Stage I Colon Cancer Patients.
    Zengin M
    Pathol Res Pract; 2019 Nov; 215(11):152635. PubMed ID: 31564570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
    Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
    Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour budding in preoperative biopsy specimens is a useful prognostic index for identifying high-risk patients in early-stage (pN0) colon cancer.
    Zengin M; Çifci A
    Turk J Med Sci; 2020 Apr; 50(2):375-385. PubMed ID: 32011836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
    Eriksen AC; Andersen JB; Lindebjerg J; dePont Christensen R; Hansen TF; Kjær-Frifeldt S; Sørensen FB
    Diagn Pathol; 2018 Mar; 13(1):20. PubMed ID: 29558947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
    Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
    BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.
    Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T
    Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high tumour-stroma ratio (TSR) in colon tumours and its metastatic lymph nodes predicts poor cancer-free survival and chemo resistance.
    Strous MTA; Faes TKE; Gubbels ALHM; van der Linden RLA; Mesker WE; Bosscha K; Bronkhorst CM; Janssen-Heijnen MLG; Vogelaar FJ; de Bruïne AP
    Clin Transl Oncol; 2022 Jun; 24(6):1047-1058. PubMed ID: 35064453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Proportion of Tumour-Stroma in Metastatic Lymph Nodes is An Accurately Prognostic Indicator of Poor Survival for Advanced-Stage Colon Cancers.
    Zengin M; Benek S
    Pathol Oncol Res; 2020 Oct; 26(4):2755-2764. PubMed ID: 32696416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study.
    Smit MA; van Pelt GW; Terpstra V; Putter H; Tollenaar RAEM; Mesker WE; van Krieken JHJM
    Int J Colorectal Dis; 2021 Dec; 36(12):2729-2737. PubMed ID: 34533595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour budding and tumour-stroma ratio in hepatocellular carcinoma.
    Kairaluoma V; Kemi N; Pohjanen VM; Saarnio J; Helminen O
    Br J Cancer; 2020 Jul; 123(1):38-45. PubMed ID: 32362654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.
    Di Narzo AF; Tejpar S; Rossi S; Yan P; Popovici V; Wirapati P; Budinska E; Xie T; Estrella H; Pavlicek A; Mao M; Martin E; Scott W; Bosman FT; Roth A; Delorenzi M
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25246611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding.
    Dourado MR; Miwa KYM; Hamada GB; Paranaíba LMR; Sawazaki-Calone Í; Domingueti CB; Ervolino de Oliveira C; Furlan ECB; Longo BC; Almangush A; Salo T; Coletta RD
    Histopathology; 2020 May; 76(6):906-918. PubMed ID: 31984527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local Inflammatory Response Can Predict Clinical Outcome in Patients with Curatively Resected Stage-IIB Colon Cancer: An Advanced Methodological Study.
    Zengin M
    Pathol Oncol Res; 2020 Jul; 26(3):1805-1816. PubMed ID: 31748877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer.
    Lai YH; Wu LC; Li PS; Wu WH; Yang SB; Xia P; He XX; Xiao LB
    Colorectal Dis; 2014 Apr; 16(4):259-64. PubMed ID: 24118729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of tumour-infiltrating T lymphocytes in stage IIA (T3N0) colon cancer: A broad methodological study in a fairly homogeneous population.
    Zengin M
    Ann Diagn Pathol; 2019 Aug; 41():69-78. PubMed ID: 31146180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological Predictors of Recurrence in Stage III Colon Cancer: Reappraisal of Tumor Deposits and Tumor Budding Using AJCC8 Criteria.
    Landau MA; Zhu B; Akwuole FN; Pai RK
    Int J Surg Pathol; 2019 Apr; 27(2):147-158. PubMed ID: 29992847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance for early stages of colon cancer: potentials for optimizing follow-up protocols.
    Gilardoni E; Bernasconi DP; Poli S; Garancini M; Luperto M; Zucchini N; Bovo G; Totis M; Bugatti A; Gianotti L
    World J Surg Oncol; 2015 Aug; 13():260. PubMed ID: 26311420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation.
    Lv Z; Cai X; Weng X; Xiao H; Du C; Cheng J; Zhou L; Xie H; Sun K; Wu J; Zheng S
    Surgery; 2015 Jul; 158(1):142-50. PubMed ID: 25890776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-stroma ratio and prognosis in gastric adenocarcinoma.
    Kemi N; Eskuri M; Herva A; Leppänen J; Huhta H; Helminen O; Saarnio J; Karttunen TJ; Kauppila JH
    Br J Cancer; 2018 Aug; 119(4):435-439. PubMed ID: 30057407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Node-negative colon cancer: histological, molecular, and stromal features predicting disease recurrence.
    Strous MTA; van der Linden RLA; Gubbels ALHM; Faes TKE; Bosscha K; Bronkhorst CM; Janssen-Heijnen MLG; de Bruïne AP; Vogelaar FJ
    Mol Med; 2023 Jun; 29(1):77. PubMed ID: 37344790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.